Conditions: Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma; Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Gastric Mucosa-Associated Lymphoid Tissue Lymphoma; Marginal Zone Lymphoma; Nodal Marginal Zone Lymphoma; Primary Cutaneous Marginal Zone Lymphoproliferative Disorder; Splenic Marginal Zone Lymphoma
Interventions: Procedure: Biopsy Procedure; Procedure: Biospecimen Collection; Procedure: Bone Marrow Biopsy; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Drug: Nemtabrutinib; Procedure: Positron Emission Tomography; Biological: Rituximab
Sponsors: City of Hope Medical Center; National Cancer Institute (NCI)
Not yet **RECRUITING NOW**
Interventions: Procedure: Biopsy Procedure; Procedure: Biospecimen Collection; Procedure: Bone Marrow Biopsy; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Drug: Nemtabrutinib; Procedure: Positron Emission Tomography; Biological: Rituximab
Sponsors: City of Hope Medical Center; National Cancer Institute (NCI)
Not yet **RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
